Plasma von Willebrand Factor and ADAMTS13 Interact With APOE ‐ε4 in Predicting Longitudinal Brain Atrophy and Cognitive Decline Over a 9‐Year Follow‐Up
Journal of the American Heart Association · 05.05.2026 · 15 (9)
DOI: 10.1161/jaha.125.043186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 05.05.2026. Verfasst von Hailey A Adegboye und 22 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Memory and Alzheimer's Center Vanderbilt University School of Medicine Nashville TN USA. Hauptthemen laut MEDLINE: von Willebrand Factor, ADAMTS13 Protein, Apolipoprotein E4, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Background
Von Willebrand factor (VWF) and ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) are linked to dementia risk, and limited evidence suggests apolipoprotein E ( APOE )‐ε4 alters VWF release. This study assessed whether baseline VWF and ADAMTS13 levels predict neurodegeneration and cognitive decline and evaluated effect modification by APOE‐ε4 carriership.
Methods
Vanderbilt Memory and Aging Project cohort participants (n=332, 73±7 years, 59% male) completed serial blood draw, neuropsychological assessment, and brain magnetic resonance imaging over 6.4 years (range 1.4–9.7 years). Baseline plasma VWF and ADAMTS13 levels were quantified using mass spectrometry and Olink. Fully adjusted linear mixed‐effects models related protein×time and protein×APOE‐ε4×time interaction terms to longitudinal brain magnetic resonance imaging and neuropsychological outcomes.
Results
Lower baseline ADAMTS13 predicted faster declines in language (β=0.11, P =0.01), information processing speed (β=0.27, P =0.001), executive function (β=0.01, P =0.03), episodic memory (β=0.01, P =0.03), and visuospatial ability (β=0.11, P =0.001) and faster increases in global (β=−0.29, P =0.01) and frontal (β=−0.17, P =0.01) white matter hyperintensity volumes. Associations between ADAMTS13 and faster rates of cognitive decline and white matter injury were driven by APOE ‐ε4 carriers. Models relating VWF to longitudinal outcomes were null. APOE ‐ε4 interacted with VWF on longitudinal gray matter volumetric outcomes, such that faster rates of global gray matter atrophy were observed with higher baseline VWF levels among APOE ‐ε4 noncarriers only (β=−1530.5, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Memory and Alzheimer's Center Vanderbilt University School of Medicine Nashville TN USA.
- Medical Scientist Training Program Vanderbilt University School of Medicine Nashville TN USA.
- Vanderbilt Brain Institute Vanderbilt University School of Medicine Nashville TN USA.
- Department of Biostatistics Vanderbilt University Medical Center Nashville TN USA.
- Department of Psychology and Human Development Vanderbilt University Nashville TN USA.
- Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
ORCID-Profile: Panpan Zhang, Dandan Liu, Omair A Khan, Kahraman Tanriverdi, Nekesa C Oliver, Marsalas D Whitaker, Vaibhav A Janve, Logan C Dumitrescu, Kimberly R Pechman, Niranjana Shashikumar, Corey J Bolton, Bennett A Landman, Jane E Freedman, Renã A S Robinson, Timothy J Hohman, Angela L Jefferson
Förderung
- NIA NIH HHS
Zitieren
APA
Adegboye, H. A., Sun, Y., Zhang, P., Liu, D., Khan, O. A., Tanriverdi, K., Risitano, A., Libby, J., Patterson, K. L., Arul, A. B., Oliver, N. C., Whitaker, M. D., Janve, V. A., Dumitrescu, L. C., Pechman, K. R., Shashikumar, N., Bolton, C. J., Davis, L. T., Landman, B. A., …, & Jefferson, A. L. (2026). Plasma von Willebrand Factor and ADAMTS13 Interact With APOE ‐ε4 in Predicting Longitudinal Brain Atrophy and Cognitive Decline Over a 9‐Year Follow‐Up. Journal of the American Heart Association, 15(9). https://doi.org/10.1161/jaha.125.043186
Vancouver
Adegboye HA, Sun Y, Zhang P, Liu D, Khan OA, Tanriverdi K, et al. Plasma von Willebrand Factor and ADAMTS13 Interact With APOE ‐ε4 in Predicting Longitudinal Brain Atrophy and Cognitive Decline Over a 9‐Year Follow‐Up. Journal of the American Heart Association. 2026;15(9). doi:10.1161/jaha.125.043186
BibTeX
@article{Adegboye2026,
author = {Adegboye, Hailey A and Sun, Yunyi and Zhang, Panpan and Liu, Dandan and Khan, Omair A and Tanriverdi, Kahraman and Risitano, Antonina and Libby, Julia and Patterson, Khiry L and Arul, Albert B and Oliver, Nekesa C and Whitaker, Marsalas D and Janve, Vaibhav A and Dumitrescu, Logan C and Pechman, Kimberly R and Shashikumar, Niranjana and Bolton, Corey J and Davis, L Taylor and Landman, Bennett A and Freedman, Jane E and Robinson, Renã A S and Hohman, Timothy J and Jefferson, Angela L},
title = {Plasma von Willebrand Factor and ADAMTS13 Interact With APOE ‐ε4 in Predicting Longitudinal Brain Atrophy and Cognitive Decline Over a 9‐Year Follow‐Up},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {9},
doi = {10.1161/jaha.125.043186}
}
EUVIMED